Volastra Therapeutics
Series A
Cancer therapies targeting chromosomal instability
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Similar Startups
OpenEvidence
Series D
Organizing the world’s medical knowledge
Centivax
Broad-spectrum vaccine
Obsidian Therapeutics
Series C
Cell and gene therapies
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Sonoma BioTherapeutics
T cell therapies for autoimmune and inflammatory diseases
Human Longevity
Series B
Early detection for longer life